Programmed cell death ligand 1 as a biomarker in head and neck cancer
Sara I Pai1, William C Faquin2
1Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Cancer Cytopathology
|May 5, 2017
Abstract
No abstract available in PubMed .


